Efficacy and Safety of Rituximab in Treating Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Efficacy and Safety of Rituximab in Treating Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis Publisher Pubmed

Ghajarzadeh M² ; Azimi A¹ ; Valizadeh Z² ; Sahraian MA¹ ; Mohammadifar M³

Source: Autoimmunity Reviews Published:2020

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Efficacy and Safety of Rituximab in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Acta Neurologica Belgica (2023)

2. The Prevalence of Cancer in Patients With Multiple Sclerosis (Ms) Who Received Rituximab: A Systematic Review and Meta-Analysis; [La Prevalencia De Cancer En Pacientes Con Esclerosis Multiple (Em) Que Recibieron Rituximab: Una Revision Sistematica Y Meta-Analisis], Neurologia (2025)

3. Evaluating the Efficacy and Safety of Zytuxtm (Rituximab, Aryogen Pharmed) in Iranian Multiple Sclerosis Patients: An Observational Study, Multiple Sclerosis and Related Disorders (2019)

Experts (# of related papers)

View all Related Experts

Mohammad Ali Sahraian (4)

Amirreza Azimi (1)

Other Related Docs

4. Risk of Cancer in Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Autoimmunity Reviews (2020)

5. Adverse Drug Reactions of Rituximab in Patients Suffering From Autoimmune Neurological Diseases, DARU# Journal of Pharmaceutical Sciences (2022)

6. Consensus Recommendations for Diagnosis and Treatment of Multiple Sclerosis: 2023 Revision of the Menactrims Guidelines, Multiple Sclerosis and Related Disorders (2024)

7. Efficacy and Safety of Rituximab in Treating Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis, Autoimmunity Reviews (2021)

8. Effect of Rituximab on the Cognitive Impairment in Patients With Secondary Progressive Multiple Sclerosis, Caspian Journal of Internal Medicine (2022)

9. Age at Menarche and Risk of Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, BMC Neurology (2019)

Style	Citing Format
MLA	Ghajarzadeh M, et al.. "Efficacy and Safety of Rituximab in Treating Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis." Autoimmunity Reviews, vol. 19, no. 8, 2020, pp. -.
APA	Ghajarzadeh M, Azimi A, Valizadeh Z, Sahraian MA, Mohammadifar M (2020). Efficacy and Safety of Rituximab in Treating Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis. Autoimmunity Reviews, 19(8), -.
Chicago	Ghajarzadeh M, Azimi A, Valizadeh Z, Sahraian MA, Mohammadifar M. "Efficacy and Safety of Rituximab in Treating Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis." Autoimmunity Reviews 19, no. 8 (2020): -.
Harvard	Ghajarzadeh M et al. (2020) 'Efficacy and Safety of Rituximab in Treating Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis', Autoimmunity Reviews, 19(8), pp. -.
Vancouver	Ghajarzadeh M, Azimi A, Valizadeh Z, Sahraian MA, Mohammadifar M. Efficacy and Safety of Rituximab in Treating Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis. Autoimmunity Reviews. 2020;19(8):-.
BibTex	@article{ author = {Ghajarzadeh M and Azimi A and Valizadeh Z and Sahraian MA and Mohammadifar M}, title = {Efficacy and Safety of Rituximab in Treating Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis}, journal = {Autoimmunity Reviews}, volume = {19}, number = {8}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Ghajarzadeh M AU - Azimi A AU - Valizadeh Z AU - Sahraian MA AU - Mohammadifar M TI - Efficacy and Safety of Rituximab in Treating Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis JO - Autoimmunity Reviews VL - 19 IS - 8 SP - EP - PY - 2020 ER -

Science Communicator Platform

Authors

Abstract